# Shenzhen Yinghe Brain Science

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/shenzhen-yinghe-brain-science

- Industry: Medical Devices & Equipment
- Headquarters: Shenzhen, China
- Total disclosed funding: $15M
- Latest round: Angel (Jan 21, 2023)
- Investors on record: 5

## About

Established in 2022 and based in Shenzhen, China, Shenzhen Yinghe Brain Science is a medical device company that focuses on developing neuromodulation and brain-computer interface technologies and products.  The company's CEO, Dr. Ruilin Zhao, graduated from Xi'an Jiaotong University's Junior Class, received a master's degree in electrical engineering and computer science in artificial intelligence from MIT, and aPh.D.D in biomedical engineering and medical physics from Harvard-MIT joint program.  Dr. Xiaoyi Min, CTO, graduated from Sichuan University and holds Ph. D.h. from Michigan State University.  He has more than 30 years of experience in neuromodulation and cardiac rhythm management product development at the U.S. headquarters of Medtronic and Abbott. Its core R&D team currently consists of more than 30 people. The company has products in development that are already in animal studies and clinical trials.

The company's main business is neuromodulation and brain-computer interface technology and product development.

## Funding rounds

- Angel, Jan 21, 2023, $15M — Lilly Asia Ventures, Snibe, Xi 'an Xijiao1896 Chuangke Coffee, Bioching Capital, Enlight Medical Technologies (Shanghai) Co., Ltd.

## Investors

- Lilly Asia Ventures (https://capitalatlas.ai/funds/lilly-asia-ventures) — Angel
- Snibe — Angel
- Xi 'an Xijiao1896 Chuangke Coffee — Angel
- Bioching Capital (https://capitalatlas.ai/funds/bioching-capital) — Angel
- Enlight Medical Technologies (Shanghai) Co., Ltd. — Angel